Weight loss drug lorcaserin was given approval by the FDA and will be marketed under the brand name Lorgress.

The panelists decided that the benefits of the weight loss drug outweigh the risks for severely obese patients.

The panel included specialists in obesity and diabetes, pediatric endocrinologists, cardiologists and toxicologists.
According to Arena Pharmaceuticals, which developed the drug, Lorqess “behaves as an appetite suppressant which helps patients lose weight by essentially causing them to feel less hunger sensations.”